Hibar DP, Westlye LT, Van Erp TGM, Rasmussen J, Leonardo CD, Faskowitz J, et al. Subcortical volumetric abnormalities in bipolar disorder. Mol Psychiatry. 2016;21:1710–6.
Article CAS PubMed PubMed Central Google Scholar
Hibar DP, Westlye LT, Doan NT, Jahanshad N, Cheung JW, Ching CRK, et al. Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group. Mol Psychiatry. 2018;23:932–42.
Article CAS PubMed Google Scholar
Abé C, Ekman CJ, Sellgren C, Petrovic P, Ingvar M, Landén M. Cortical thickness, volume and surface area in patients with bipolar disorder types I and II. J Psychiatry Neurosci. 2016;41:240–50.
Hanford LC, Nazarov A, Hall GB, Sassi RB. Cortical thickness in bipolar disorder: a systematic review. Bipolar Disord. 2016;18:4–18.
Arnone D, Cavanagh J, Gerber D, Lawrie SM, Ebmeier KP, McIntosh AM. Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis. Br J Psychiatry. 2009;195:194–201.
Selvaraj S, Arnone D, Job D, Stanfield A, Farrow TF, Nugent AC, et al. Grey matter differences in bipolar disorder: a meta-analysis of voxel-based morphometry studies. Bipolar Disord. 2012;14:135–45.
Savitz JB, Price JL, Drevets WC. Neuropathological and neuromorphometric abnormalities in bipolar disorder: View from the medial prefrontal cortical network. Neurosci Biobehav Rev. 2014;42:132–47.
Article CAS PubMed Google Scholar
Maller JJ, Thaveenthiran P, Thomson RH, McQueen S, Fitzgerald PB. Volumetric, cortical thickness and white matter integrity alterations in bipolar disorder type I and II. J Affect Disord. 2014;169:118–27.
Passos IC, Mwangi B, Vieta E, Berk M, Kapczinski F. Areas of controversy in neuroprogression in bipolar disorder. Acta Psychiatr Scand. 2016;134:91–103.
Article CAS PubMed Google Scholar
Cardoso T, Bauer IE, Meyer TD, Kapczinski F, Soares JC. Neuroprogression and cognitive functioning in bipolar disorder: a systematic review. Curr Psychiatry Rep. 2015;17:75.
Barbosa IG, Bauer ME, Machado-Vieira R, Teixeira AL. Cytokines in bipolar disorder: paving the way for neuroprogression. Neural Plast. 2014;2014:1–9.
Schneider MR, DelBello MP, McNamara RK, Strakowski SM, Adler CM. Neuroprogression in bipolar disorder. Bipolar Disord. 2012;14:356–74.
Serafini G, Pardini M, Monacelli F, Orso B, Girtler N, Brugnolo A, et al. Neuroprogression as an illness trajectory in bipolar disorder: a selective review of the current literature. Brain Sci. 2021;11:276.
Article CAS PubMed PubMed Central Google Scholar
Lim CS, Baldessarini RJ, Vieta E, Yucel M, Bora E, Sim K. Longitudinal neuroimaging and neuropsychological changes in bipolar disorder patients: review of the evidence. Neurosci Biobehav Rev. 2013;37:418–35.
Martino DJ, Samamé C, Marengo E, Igoa A, Strejilevich SA. A critical overview of the clinical evidence supporting the concept of neuroprogression in bipolar disorder. Psychiatry Res. 2016;235:1–6.
Abé C, Ekman C-J, Sellgren C, Petrovic P, Ingvar M, Landén M. Manic episodes are related to changes in frontal cortex: a longitudinal neuroimaging study of bipolar disorder 1. Brain. 2015;138:3440–8.
Abé C, Liberg B, Song J, Bergen SE, Petrovic P, Ekman CJ, et al. Longitudinal cortical thickness changes in bipolar disorder and the relationship to genetic risk, mania, and lithium use. Biol Psychiatry. 2020;87:271–81.
Moorhead TWJ, McKirdy J, Sussmann JED, Hall J, Lawrie SM, Johnstone EC, et al. Progressive gray matter loss in patients with bipolar disorder. Biol Psychiatry. 2007;62:894–900.
Zak N, Bøen E, Boye B, Andreassen OA, Doan NT, Malt UF, et al. Mood episodes are associated with increased cortical thinning: A longitudinal study of bipolar disorder type II. Bipolar Disord. 2019;21:525–38.
Kozicky J-M, McGirr A, Bond DJ, Gonzalez M, Silveira LE, Keramatian K, et al. Neuroprogression and episode recurrence in bipolar I disorder: A study of gray matter volume changes in first-episode mania and association with clinical outcome. Bipolar Disord. 2016;18:511–9.
Abé C, Ching CRK, Liberg B, Lebedev AV, Agartz I, Akudjedu TN, et al. Longitudinal structural brain changes in bipolar disorder: a multicenter neuroimaging study of 1232 individuals by the ENIGMA bipolar disorder working group. Biol Psychiatry. 2022;91:582–92.
Cahn AJ, Keramatian K, Frysch C, Yatham LN, Chakrabarty T. Longitudinal grey matter changes following first episode mania in bipolar I disorder: a systematic review. J Affect Disord. 2021;291:198–208.
Ho B-C, Andreasen NC, Ziebell S, Pierson R, Magnotta V. Long-term antipsychotic treatment and brain volumes. Arch Gen Psychiatry. 2011;68:128.
Article PubMed PubMed Central Google Scholar
McDonald C. Brain structural effects of psychopharmacological treatment in bipolar disorder. Curr Neuropharmacol. 2015;13:445–57.
Article CAS PubMed PubMed Central Google Scholar
Panizzon MS, Fennema-Notestine C, Eyler LT, Jernigan TL, Prom-Wormley E, Neale M, et al. Distinct genetic influences on cortical surface area and cortical thickness. Cereb Cortex. 2009;19:2728–35.
Article PubMed PubMed Central Google Scholar
Winkler AM, Kochunov P, Blangero J, Almasy L, Zilles K, Fox PT, et al. Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies. Neuroimage. 2010;53:1135–46.
Fischl B, Sereno MI, Dale AM. Cortical surface-based analysis. Neuroimage. 1999;9:195–207.
Article CAS PubMed Google Scholar
Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. Neuroimage. 1999;9:179–94.
Article CAS PubMed Google Scholar
Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci. 2000;97:11050–5.
Article CAS PubMed PubMed Central Google Scholar
Rakic P. Specification of cerebral cortical areas. Science. 1979;1988;241:170–6.
Abé C, Rolstad S, Petrovic P, Ekman CJ, Sparding T, Ingvar M, et al. Bipolar disorder type I and II show distinct relationships between cortical thickness and executive function. Acta Psychiatr Scand. 2018;138:325–35.
Article PubMed PubMed Central Google Scholar
Anand A, Nakamura K, Spielberg JM, Cha J, Karne H, Hu B. Integrative analysis of lithium treatment associated effects on brain structure and peripheral gene expression reveals novel molecular insights into mechanism of action. Transl Psychiatry. 2020;10:103.
Article PubMed PubMed Central Google Scholar
Hajek T, Bauer M, Simhandl C, Rybakowski J, O’Donovan C, Pfennig A, et al. Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response. Psychol Med. 2014;44:507–17.
Article CAS PubMed Google Scholar
Berk M, Dandash O, Daglas R, Cotton SM, Allott K, Fornito A, et al. Neuroprotection after a first episode of mania: a randomized controlled maintenance trial comparing the effects of lithium and quetiapine on grey and white matter volume. Transl Psychiatry. 2017;7:e1011–e1011.
Article CAS PubMed PubMed Central Google Scholar
Dwivedi T, Zhang H. Lithium-induced neuroprotection is associated with epigenetic modification of specific BDNF gene promoter and altered expression of apoptotic-regulatory proteins. Front Neurosci. 2015;8:457.
Article PubMed PubMed Central Google Scholar
Sun YR, Herrmann N, Scott CJM, Black SE, Khan MM, Lanctôt KL. Global grey matter volume in adult bipolar patients with and without lithium treatment: a meta-analysis. J Affect Disord. 2018;225:599–606.
Monkul ES, Matsuo K, Nicoletti MA, Dierschke N, Hatch JP, Dalwani M, et al. Prefrontal gray matter increases in healthy individuals after lithium treatment: a voxel-based morphometry study. Neurosci Lett. 2007;429:7–11.
Article CAS PubMed PubMed Central Google Scholar
Lyoo IK, Dager SR, Kim JE, Yoon SJ, Friedman SD, Dunner DL, et al. Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study. Neuropsychopharmacology. 2010;35:1743–50.
留言 (0)